Ret 160 5562 Pill - pink round
Generic Name: selpercatinib
Pill with imprint Ret 160 5562 is Pink, Round and has been identified as Retevmo 160 mg. It is supplied by Eli Lilly and Company.
Retevmo is used in the treatment of Non Small Cell Lung Cancer; Solid Tumors; Thyroid Cancer and belongs to the drug class multikinase inhibitors. Retevmo 160 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Ret 160 5562
Retevmo
- Generic Name
- selpercatinib
- Imprint
- Ret 160 5562
- Strength
- 160 mg
- Color
- Pink (light pink)
- Shape
- Round (film-coated)
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Eli Lilly and Company
- National Drug Code (NDC)
- 00002-5562
More about Retevmo (selpercatinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (4)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.